- Home
- NEXM vs ORMP Comparison
NEXM vs ORMP Comparison
Compare NEXM & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NEXM | ORMP |
|---|---|---|
| Founded | N/A | 2002 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.5M | 134.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NEXM | ORMP |
|---|---|---|
| Price | $3.28 | $3.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 109.1K | ★ 196.7K |
| Earning Date | 03-20-2026 | 03-26-2026 |
| Dividend Yield | N/A | ★ 7.72% |
| EPS Growth | N/A | ★ 838.25 |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.16 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.31 | $1.82 |
| 52 Week High | $10.35 | $3.71 |
Technical Indicators
Market Signals| Indicator | NEXM | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 37.99 | 46.07 |
| Support Level | $3.35 | $3.14 |
| Resistance Level | $3.69 | $3.51 |
| Average True Range (ATR) | 0.30 | 0.16 |
| MACD | -0.07 | -0.04 |
| Stochastic Oscillator | 12.26 | 18.89 |
Price Performance
Historical ComparisonAbout NEXM NexMetals Mining Corp.
NexMetals Mining Corp is a mineral exploration and development company focused on discovering and advancing high-quality copper-nickel-cobalt-platinum element metals (Cu- Cu-Ni-Co-PGE) resources. The group prioritizes projects in stable, mining-friendly jurisdictions with supportive foreign investment and rule-of-law standards. Its projects are Botswana and Canada.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.